Cannabis company Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) said Monday it has closed on the previously announced purchase of an Arizona-based cannabis extract brand, Venom Extracts.
Last year, Venom Brands disclosed revenue of CA$16.4 million ($11.58 million), reaching positive EBITDA of over CA$2.4 million from its line of cannabis concentrates and cartridges, according to the press release. The company is projecting record first-quarter revenue.
The all-stock purchase price …
Full story available on Benzinga.com
More Hollister Biosciences Buys Venom Extracts In 'Highly Accretive' Deal